Insider filing · AMGN
Matthew C. Busch
VP, Finance & CAO
profile →
Amgen Inc.
AMGN · Healthcare · 48 filings in 24 months
ticker →
Matthew C. Busch sold $280K of Amgen (AMGN)
Executed May 2 2025, disclosed May 6 2025, 4 days later.
Value, as filed
$280K
1,000 sh × $279.69
Executed
May 2 2025
the trade date, as filed
Disclosed
May 6 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MBMatthew C. Busch (VP, Finance & CAO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Amgen Inc. (AMGN). The largest single filing was $376K of AMGN (1,000 sh × $375.79, as filed), executed Feb 19.
The name
AMGNHealthcare · Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Matthew C. Busch in AMGN
AMGNSALE
Amgen Inc.
$376K1,000 sh × $375.79
Exec Feb 19
Filed Feb 20 · 5:30 PM ET